The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women
Received: 01-Jun-2023 / Manuscript No. jpch-23-102372 / Editor assigned: 05-Jun-2023 / PreQC No. jpch-23-102372 (PQ) / Reviewed: 14-Jun-2023 / QC No. jpch-23-102372 / Revised: 21-Jun-2023 / Manuscript No. Jpch-23-102372(R) / Accepted Date: 30-Jun-2023 / Published Date: 30-Jun-2023 DOI: 10.4172/2376-127X.1000595
Abstract
Objective: to investigate the effects of a novel multi-ingredient supplement comprised of high dose whey protein, to improve maternal and perinatal outcomes in pregnant women
Methods: This was an observational retrospective study. Women who received oral supplementation with a novel multi-ingredient supplement (PSIPROTO ®), comprised of high dose whey protein, were compared with women who did not. Inclusion criteria were singleton pregnancy with body mass index (BMI) higher than 25. The primary outcome of the study was the incidence of adverse pregnancy outcome
Results: 400 women, 200 for each group, were included in the study. The two groups were similar in terms of maternal demographics, and both of them had similar BMI. Maternal age and smoking rate were also similar. Women who received the intervention had a significantly lower maternal weight gain, and lower risk of low birth weight. Notably, 4 women in the intervention group reported intrauterine growth restriction before the intervention, and solved after 2 months of supplementation.
Conclusion: Our retrospective cohort of singleton gestations with BMI >25 showed that PSIPROTO is a safe and efficacy supplement in pregnancy.
Keywords
Supplementation; Iron; Anemia; Pregnancy; Diet; Protein
Introduction
In pregnant women, a healthy lifestyle includes appropriate weight gain, a balanced diet, regular aerobix exercise, and appropriate vitamin and mineral supplementation [1-3]. Every day approximately 300 extra calories are needed, with a balanced diet of protein, fruits, vegetalbes and whole grains [4]. Animal-based foods (meat, poultry, fish, eggs, and dairy foods) tend to be good sources of complete protein, while plantbased foods (fruits, vegetables, grains, nuts, and seeds) often lack one or more essential amino acid [5]. Proteins are of paramount importance during pregnancy. A pregnant patient should get a minimum of 60 grams of protein a day, which account for approximately 20-25% of the total calorie intake [6]. Whey protein comprises soluble whey proteins and its benefits are well described in the literature [7]. During pregnancy, whey protein intake and high protein supplementation are associated with reduced risk of excessive maternal weight gain [8].
Materials and Methods
This was an observational retrospective study. Data were collected in a dedicated encrypted database and anonymized. Women who received oral supplementation with a novel multi-ingredient supplement (PSIPROTO ®), comprised of high dose whey protein, were compared with women who did not. PSIPROTO ® contains a blend called PSINOTRIP ®, and Volactive ® as source of UltraWhey high-performance proteins (7.6 grams for 10 gr of PSIPROTO). PSINOTRIP included for 10 gr of PSIPROTO the following: psyllium fiber (0.5 g); myoinositol (0.5 g); L-Tryptophan (0.15 g); Magnesium bisglycinate (0.1 g); and vitamin D (1.000 UI). The intervention was taken at the dose of 20 gr per day starting from 14 weeks for 3 months (until 26 weeks). Inclusion criteria were singleton pregnancy with body mass index (BMI) higher than 25. Exclusion criteria were twin pregnancies and multiple gestations. The primary outcome of the study was the incidence of adverse pregnancy outcome, including maternal and perinatal outcomes. The secondary outcomes were maternal weight gain, and birth weight. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY, USA). Data were shown as means± standard deviation or as number (percentage). Dichotomous data were compared using the chi-square. Comparisons between groups were performed with the use of the T-test to test group means by assuming equal within-group variances. A sample size of 200 women for each group was planned.
Results
400 women, 200 for each group were included in the study. Therefore, 388 participants were available for the final analysis. The two groups were similar in terms of maternal demographics, and both of them had similar BMI. Maternal age and smoking rate were also similar. Women who received the intervention had a significantly lower maternal weight gain, with a mean difference of -5.50 kg, and lower risk of low birth weight. Notably, 4 women in the intervention group reported intrauterine growth restriction before the intervention, and solved after 2 months of supplementation. However, the sample size was too sample to run statistics [Table 1]
Intervention group | Control group | P-value | |
---|---|---|---|
N = 190 | N = 198 | ||
Maternal weight gain (kg) | 8.3±3.5 | 13.8±7.4 | <0.01 |
>15kg during pregnancy | 20 (10.5%) | 37 (18.7%) | 0.03 |
Intrauterine growth restriction | 13 (6.8%) | 18 (9.1%) | NS |
Miscarriage | 7 (3.7%) | 5 (2.5%) | NS |
Cesarean delivery | 51 (26.8%) | 63 (31.8%) | NS |
Low birth weight | 18 (9.5%) | 35 (17.7%) | 0.02 |
Fetal macrosomia | 12 | 16 | NS |
Boldaface data, statistically significant |
Table 1: Primary and secondary outcomes.
Conclusion
Our retrospective cohort of singleton gestations showed that that PSIPROTO ® is a safe and efficacy supplement in pregnancy that improves maternal and perinatal outcome. Future, large well-designed placebo-controlled randomized trials are needed to confirm our findings.
References
- Berghella V, Saccone G (2017) Exercise in pregnancy! Am J Obstet Gynecol 216: 335-337.
- Saccone G, Saccone I, Berghella V(2016) Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? J Matern Fetal Neonatal Med 29: 2389-97.
- Menezes R, Lelijveld N, Wrottesley SV, Brennan E, Mates E, et al. (2022) Integrating Women and Girls' Nutrition Services into Health Systems in Low- and Middle-Income Countries: A Systematic Review. Nutrients 14: 4488.
- Elliott Sale KJ, Graham A, Hanley SJ, Blumenthal S, Sale C, et al. (2019) Modern dietary guidelines for healthy pregnancy; maximising maternal and foetal outcomes and limiting excessive gestational weight gain. Eur J Sport Sci 19: 62-70.
- Koletzko B, Cremer M, Flothkötter M, Graf C, Hauner H, et al. (2018). Diet and Lifestyle Before and During Pregnancy - Practical Recommendations of the Germany-wide Healthy Start - Young Family Network. Geburtshilfe Frauenheilkd 78: 1262-1282.
- Koletzko B, Bauer CP, Bung P, Cremer M, Flothkötter M, et al. (2013) German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'. Ann Nutr Metab 63: 311-22.
- Vasconcelos QDJS, Bachur TPR, Aragão GF (2021) Whey protein supplementation and its potentially adverse effects on health: a systematic review. Appl Physiol Nutr Metab 46: 27-33.
- Clark DC (2018) Association of Dairy Protein Intake During Pregnancy with Birth Weight. Food Nutr Bull 39: S54-S59.
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Indexed at, Crossref, Google Scholar
Citation: Rigatti M, Menditto A, Stefano RD, Antonio C, Landri U, et al. (2023) The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women. J Preg Child Health 10: 595. DOI: 10.4172/2376-127X.1000595
Copyright: © 2023 Rigatti M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1775
- [From(publication date): 0-2023 - Dec 09, 2024]
- Breakdown by view type
- HTML page views: 1666
- PDF downloads: 109